Information Library

ECG

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • The New Health Clinical Brochure

    August 31, 2010
    Japanese version available for download.

  • Applications of Modeling and Simulation

    May 27, 2010
    Applications of Modeling and Simulation is discussed by Giridhar S. Tirucherai PhD, Director, Clinical PK-PD at Quintiles in the April issue of DIA Global Forum.

  • Assessing Cardiac Safety Throughout Clinical Development

    May 27, 2010
    Assessing Cardiac Safety Throughout Clinical Development and the ramifications for an integrated cardiac safety program is discussed by Rick Turner, Senior Scientific Director at Quintiles in the April issue of DIA Global Forum.

  • EMA’s Guidance on New Antidiabetic Drug Development

    May 12, 2010
    Assessing the EMA’s Guidance on New Antidiabetic Drug Development In January 2010, the European Medicines Agency (EMA) issued a draft guideline on antidiabetic drug development

  • Turnkey TQT Solutions

    April 13, 2010
    At Quintiles, we offer you a complete solution for your TQT needs including our Phase I, Clinical Pharmacology and ECG Core Labs.

  • Clinical – smarter trials, accelerated outcomes

    April 2, 2010
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • PharmAsia News Article Reprint

    March 1, 2010
    Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.

  • Journal for Clinical Studies

    February 19, 2010
    In the January 2010 Journal for Clinical Studies, Dr. Erica Caveney and Dr. Rick Turner analyze the FDA Guidance on diabetes drugs and cardiovascular risk.

  • New FDA Guidance on Antidiabetic Therapies

    December 11, 2009
    Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program.

  • Applications of Modeling and Simulation (M&S) in Cardiac Safety Studies

    December 10, 2009
    Why are modeling and simulation important in cardiac safety? How are they different? In this presentation from the October 2009 DIA webinar on cardiac safety,

Page 1 of 2 (13 results)

Subscribe to Email Based on Your Interests

Set preferences